Back to search
Short Gut Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Short Gut Syndrome trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Short Gut Syndrome trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The main aim of the study is to assess how well teduglutide works over 24 weeks in Chinese adult participants with short bowel syndrome (SBS) who need parentera…
A 24-week, randomized, placebo-controlled, double-blind study to evaluate the efficacy, safety and tolerability of crofelemer in patients with Short Bowel Syndr…
Eligible patients were randomized into two groups: the GLP-1 group and the control group. The control group received a placebo along with standard care, without…
This is a randomized, double-blind, placebo-controlled, proof-of-concept (PoC), Phase 2 study to assess the safety, PK, and PD of SC administration of HM15912(s…
The purpose of the present Phase 3 trial is to confirm the efficacy and safety of glepaglutide 10 mg twice weekly in a patient population with SBS-IF and genera…
This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors tha…
This prospective and observational study aims to evaluate the accumulation of advanced glycation end-products (AGEs) in adult and pediatric patients starting lo…
This is a randomized controlled, parallel group, open label versus "no treatment" trial which evaluate the efficacy of rhGH on weaning off parenteral nutrition…